Suplatast tosilate, a novel anti-allergic drug, in asthmatic patients receiving high-dose inhaled corticosteroids

被引：0
|
作者：
Tamaoki, J
Kondo, M
Tagaya, E
Nagano, Y
Nagal, A
Kawagoe, M
Hanyu, F
机构：
[1] Hamacho Ctr Build Clin, Tokyo, Japan
[2] Tokyo Womens Univ, Dept Med 1, Sch Med, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A625 / A625
页数：1
相关论文
共 50 条
  • [1] Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug
    Suwaki, T
    Agrawal, DK
    Townley, RG
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (12) : 2163 - 2171
  • [2] INHALED SALMETEROL AND ALBUTEROL IN ASTHMATIC-PATIENTS RECEIVING HIGH-DOSE INHALED CORTICOSTEROIDS
    LAI, CKW
    CHAN, CHS
    HO, SS
    HUI, ACF
    LAI, KN
    CHEST, 1995, 108 (01) : 36 - 40
  • [3] DUPILUMAB EFFICACY IN PATIENTS WITH TYPE 2 ASTHMA WITH/WITHOUT ALLERGIC PHENOTYPE RECEIVING HIGH-DOSE INHALED CORTICOSTEROIDS
    Bourdin, A.
    Virchow, J.
    Papi, A.
    Lugogo, N.
    Halpin, D.
    Daizadeh, N.
    Ortiz, B.
    Djandji, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S32 - S33
  • [4] Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids
    Virchow, JC
    Prasse, A
    Naya, I
    Summerton, L
    Harris, A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) : 578 - 585
  • [5] Interaction of suplatast tosilate (IPD) with chloride channels in human blood eosinophils: a potential mechanism underlying its anti-allergic and anti-asthmatic effects
    Agrawal, D. K.
    Cheng, G.
    Kim, M. -J.
    Kiniwa, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2008, 38 (02): : 305 - 312
  • [6] USEFULNESS OF INHALED HIGH-DOSE CORTICOSTEROIDS IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
    IMBEAULT, B
    CORMIER, Y
    CHEST, 1993, 103 (05) : 1614 - 1617
  • [7] CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate
    Woerly, G
    Decot, V
    Loiseau, S
    Loyens, M
    Chihara, J
    Ono, N
    Capron, M
    CLINICAL AND EXPERIMENTAL ALLERGY, 2004, 34 (09): : 1379 - 1387
  • [8] Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: A prospective study for 18 months
    Wang, WQ
    Ip, MSM
    Tsang, KWT
    Lam, KSL
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (04) : 445 - 450
  • [9] Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline
    Bourdin, Arnaud
    Papi, Alberto A.
    Corren, Jonathan
    Virchow, J. Christian
    Rice, Megan S.
    Deniz, Yamo
    Djandji, Michel
    Rowe, Paul
    Pavord, Ian D.
    ALLERGY, 2021, 76 (01) : 269 - 280
  • [10] The effect of high-dose inhaled budesonide on lipid profile in asthmatic patients
    Yavuz, O
    Turktas, I
    Cevik, C
    GENERAL PHARMACOLOGY, 1996, 27 (01): : 89 - 90
12345